{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T18:11:16Z","timestamp":1792692676539,"version":"4.5.0"},"reference-count":141,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2019,6,30]],"date-time":"2019-06-30T00:00:00Z","timestamp":1561852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","award":["TS-2012-08-M\u00e9lanomes"],"award-info":[{"award-number":["TS-2012-08-M\u00e9lanomes"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","award":["INCa PLBio-2012-2016-M\u00e9lanomes"],"award-info":[{"award-number":["INCa PLBio-2012-2016-M\u00e9lanomes"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>Despite recent genetic advances and numerous ongoing therapeutic trials, malignant melanoma remains fatal, and prognostic factors as well as more efficient treatments are needed. The development of such research strongly depends on the availability of appropriate models recapitulating all the features of human melanoma. The concept of comparative oncology, with the use of spontaneous canine models has recently acquired a unique value as a translational model. Canine malignant melanomas are naturally occurring cancers presenting striking homologies with human melanomas. As for many other cancers, dogs present surprising breed predispositions and higher frequency of certain subtypes per breed. Oral melanomas, which are much more frequent and highly severe in dogs and cutaneous melanomas with severe digital forms or uveal subtypes are subtypes presenting relevant homologies with their human counterparts, thus constituting close models for these human melanoma subtypes. This review addresses how canine and human melanoma subtypes compare based on their epidemiological, clinical, histological, and genetic characteristics, and how comparative oncology approaches can provide insights into rare and poorly characterized melanoma subtypes in humans that are frequent and breed-specific in dogs. We propose canine malignant melanomas as models for rare non-UV-induced human melanomas, especially mucosal melanomas. Naturally affected dogs offer the opportunity to decipher the genetics at both germline and somatic levels and to explore therapeutic options, with the dog entering preclinical trials as human patients, benefiting both dogs and humans.<\/jats:p>","DOI":"10.3390\/genes10070501","type":"journal-article","created":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T03:23:59Z","timestamp":1561951439000},"page":"501","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":135,"title":["Canine Melanomas as Models for Human Melanomas: Clinical, Histological, and Genetic Comparison"],"prefix":"10.3390","volume":"10","author":[{"given":"Ana\u00efs","family":"Prouteau","sequence":"first","affiliation":[{"name":"Univ Rennes, CNRS, IGDR - UMR 6290, F-35000 Rennes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Andr\u00e9","sequence":"additional","affiliation":[{"name":"Univ Rennes, CNRS, IGDR - UMR 6290, F-35000 Rennes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,6,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1146\/annurev-pathol-012513-104658","article-title":"The molecular pathology of melanoma: An integrated taxonomy of melanocytic neoplasia","volume":"9","author":"Bastian","year":"2014","journal-title":"Annu. Rev. Pathol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"4108","DOI":"10.1002\/cncr.29634","article-title":"Revisiting determinants of prognosis in cutanous melanoma","volume":"121","author":"Weiss","year":"2015","journal-title":"Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s12105-017-0789-y","article-title":"Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Mucosal Melanomas","volume":"11","author":"Williams","year":"2017","journal-title":"Head Neck Pathol."},{"key":"ref_4","unstructured":"LeBoit, P.E., Burg, G., Weedon, D., and Sarasain, A. (2006). World Health Organization Classification of Tumours. Pathology and Genetics of Skin Tumours, IARC Press."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/CMR.0b013e32834e6aa0","article-title":"Superficial spreading and nodular melanoma are distinct biological entities: A challenge to the linear progression model","volume":"22","author":"Greenwald","year":"2012","journal-title":"Melanoma Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1101\/gad.191999.112","article-title":"Melanoma: From mutations to medicine","volume":"26","author":"Tsao","year":"2012","journal-title":"Genes Dev."},{"key":"ref_7","first-page":"1071","article-title":"Cutaneous melanoma: From pathogenesis to therapy (Review)","volume":"52","author":"Leonardi","year":"2018","journal-title":"Int. J. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/labinvest.2013.116","article-title":"Melanoma Stem Cells and Metastasis: Mimicking Hematopoietic Cell Trafficking?","volume":"94","author":"Lee","year":"2014","journal-title":"Lab. Investig."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/path.4204","article-title":"Genome sequencing of mucosal melanomas reveals that they are driven by distinct mechanisms from cutaneous melanoma","volume":"230","author":"Furney","year":"2013","journal-title":"J. Pathol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1093\/annonc\/mdw694","article-title":"The natural history and patterns of metastases from mucosal melanoma: An analysis of 706 prospectively-followed patients","volume":"28","author":"Lian","year":"2017","journal-title":"Ann. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2217\/mmt-2016-0017","article-title":"Improving the diagnosis and treatment of acral melanocytic lesions","volume":"4","author":"Criscito","year":"2017","journal-title":"Melanoma Manag."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s11912-018-0675-0","article-title":"Mucosal Melanoma: A Literature Review","volume":"20","author":"Yde","year":"2018","journal-title":"Curr. Oncol. Rep."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"231693","DOI":"10.1155\/2012\/231693","article-title":"Rising Incidence of Mucosal Melanoma of the Head and Neck in the United States","volume":"2012","author":"Marcus","year":"2012","journal-title":"J. Skin Cancer"},{"key":"ref_14","unstructured":"Kirchoff, D.D., Deutsch, G.B., Foshag, L.J., Lee, J.H., Sim, M.-S., and Faries, M.B. (2019, April 25). Evolving Therapeutic Strategies in Mucosal Melanoma Have not Improved Survival Over Five Decades. Available online: https:\/\/www.ingentaconnect.com\/content\/sesc\/tas\/2016\/00000082\/00000001\/art00002."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1136\/bjophthalmol-2015-306810","article-title":"Epidemiological trends in uveal melanoma","volume":"99","author":"Andreoli","year":"2015","journal-title":"Br. J. Ophthalmol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/S0161-6420(00)00182-2","article-title":"Tumor doubling times in metastatic malignant melanoma of the uvea: Tumor progression before and after treatment","volume":"107","author":"Eskelin","year":"2000","journal-title":"Ophthalmology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ccell.2017.12.013","article-title":"Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma","volume":"33","author":"Robertson","year":"2018","journal-title":"Cancer Cell"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/path.4632","article-title":"Cross-species models of human melanoma","volume":"238","author":"Patton","year":"2016","journal-title":"J. Pathol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1146\/annurev-animal-022114-110911","article-title":"Dogs as a Model for Cancer","volume":"4","author":"Gardner","year":"2016","journal-title":"Annu. Rev. Anim. Biosci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1146\/annurev-animal-030117-014523","article-title":"Canine Cancer Genomics: Lessons for Canine and Human Health","volume":"7","author":"Ostrander","year":"2019","journal-title":"Annu. Rev. Anim. Biosci."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Schiffman, J.D., and Breen, M. (2015). Comparative oncology: What dogs and other species can teach us about humans with cancer. Philos. Trans. R. Soc. B. Biol. Sci., 370.","DOI":"10.1098\/rstb.2014.0231"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.1158\/0008-5472.CAN-16-2691","article-title":"Discovery of Human-Similar Gene Fusions in Canine Cancers","volume":"77","author":"Rault","year":"2017","journal-title":"Cancer Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s10577-014-9406-z","article-title":"Genomic profiling reveals extensive heterogeneity in somatic DNA copy number aberrations of canine hemangiosarcoma","volume":"22","author":"Thomas","year":"2014","journal-title":"Chromosome Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1158\/1541-7786.MCR-14-0689","article-title":"Homologous Mutation to Human BRAF V600E Is Common in Naturally Occurring Canine Bladder Cancer\u2014Evidence for a Relevant Model System and Urine-Based Diagnostic Test","volume":"13","author":"Decker","year":"2015","journal-title":"Mol. Cancer Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1101\/gr.194449.115","article-title":"Exome sequencing of lymphomas from three dog breeds reveals somatic mutation patterns reflecting genetic background","volume":"25","author":"Elvers","year":"2015","journal-title":"Genome Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1158\/0008-5472.CAN-17-3558","article-title":"SETD2 Is Recurrently Mutated in Whole-Exome Sequenced Canine Osteosarcoma","volume":"78","author":"Sakthikumar","year":"2018","journal-title":"Cancer Res."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Arendt, M.L., Melin, M., Tonomura, N., Koltookian, M., Courtay-Cahen, C., Flindall, N., Bass, J., Boerkamp, K., Megquir, K., and Youell, L. (2015). Genome-Wide Association Study of Golden Retrievers Identifies Germ-Line Risk Factors Predisposing to Mast Cell Tumours. PLoS Genet., 11.","DOI":"10.1371\/journal.pgen.1005647"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/vco.12357","article-title":"Gain-of-function mutation in PTPN11 in histiocytic sarcomas of Bernese Mountain Dogs","volume":"16","author":"Thaiwong","year":"2018","journal-title":"Vet. Comp. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Hendricks, W.P.D., Zismann, V., Sivaprakasam, K., Legendre, C., Poorman, K., Tembe, W., Perdigones, N., Kiefer, J., Liang, W., and DeLuca, V. (2018). Somatic inactivating PTPRJ mutations and dysregulated pathways identified in canine malignant melanoma by integrated comparative genomic analysis. PLoS Genet., 14.","DOI":"10.1371\/journal.pgen.1007589"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41467-018-08081-1","article-title":"Cross-species genomic landscape comparison of human mucosal melanoma with canine oral and equine melanoma","volume":"10","author":"Wong","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Nishiya, A.T., Massoco, C.O., Felizzola, C.R., Perlmann, E., Batschinski, K., Tedardi, M.V., Garcia, J.S., Mendon\u00e7a, P.P., Teixeira, T.F., and Zaidan Dagli, M.L. (2016). Comparative Aspects of Canine Melanoma. Vet. Sci., 3.","DOI":"10.3390\/vetsci3010007"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Hernandez, B., Adissu, H.A., Wei, B.-R., Michael, H.T., Merlino, G., and Simpson, R.M. (2018). Naturally Occurring Canine Melanoma as a Predictive Comparative Oncology Model for Human Mucosal and Other Triple Wild-Type Melanomas. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19020394"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/pcmr.12185","article-title":"Sporadic naturally occurring melanoma in dogs as a preclinical model for human melanoma","volume":"27","author":"Simpson","year":"2014","journal-title":"Pigment Cell Melanoma Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/pcmr.12170","article-title":"Naturally occurring melanomas in dogs as models for non-UV pathways of human melanomas","volume":"27","author":"Gillard","year":"2014","journal-title":"Pigment Cell Melanoma Res."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Barutello, G., Rolih, V., Arigoni, M., Tarone, L., Conti, L., Quaglino, E., Buracco, P., Cavallo, F., and Riccardo, F. (2018). Strengths and Weaknesses of Pre-Clinical Models for Human Melanoma Treatment: Dawn of Dogs\u2019 Revolution for Immunotherapy. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19030799"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1354\/vp.43-2-136","article-title":"The histologic and epidemiologic bases for prognostic considerations in canine melanocytic neoplasia","volume":"43","author":"Spangler","year":"2006","journal-title":"Vet. Pathol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1354\/vp.39-6-651","article-title":"A comparative review of melanocytic neoplasms","volume":"39","author":"Smith","year":"2002","journal-title":"Vet. Pathol."},{"key":"ref_38","unstructured":"Withrow, S.J., Vail, D.M., and Page, R.L. (2013). Withrow and MacEwen\u2019s Small Animal Clinical Oncology, Elsevier. [5th ed.]."},{"key":"ref_39","unstructured":"Prouteau, A., De Brito, C., Cadieu, E., Gillard, M., Abadie, J., Botherel, N., Degorce, F., Lagoutte, L., Lagadic, M., and Guillory, A.S. A prospective study of 420 canine melanocytic tumors: survival analysis and prognostic factors, in prep 2019."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/00480169.2012.699433","article-title":"Malignant melanoma in 63 dogs (2001\u20132011): The effect of carboplatin chemotherapy on survival","volume":"61","author":"Brockley","year":"2013","journal-title":"N. Z. Vet. J."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1177\/104063870601800422","article-title":"Histologic features and clinical outcomes of melanomas of lip, haired skin, and nail bed locations of dogs","volume":"18","author":"Schultheiss","year":"2006","journal-title":"J. Vet. Diagn. Investig."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1354\/vp.37-6-597","article-title":"Retrospective study of 338 canine oral melanomas with clinical, histologic, and immunohistochemical review of 129 cases","volume":"37","author":"Beissenherz","year":"2000","journal-title":"Vet. Pathol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1053\/j.ctsap.2007.03.004","article-title":"Canine oral melanoma","volume":"22","author":"Bergman","year":"2007","journal-title":"Clin. Tech. Small Anim. Pract."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"941275","DOI":"10.1155\/2013\/941275","article-title":"Breed-predispositions to cancer in pedigree dogs","volume":"2013","author":"Dobson","year":"2013","journal-title":"ISRN Vet. Sci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/jsap.12637","article-title":"Malignant anal sac melanoma in dogs: Eleven cases (2000 to 2015)","volume":"58","author":"Vinayak","year":"2017","journal-title":"J. Small Anim. Pract."},{"key":"ref_46","first-page":"1051","article-title":"Spontaneous Intestinal Melanoma in Dogs","volume":"19","author":"Spugnini","year":"2005","journal-title":"In Vivo"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"472","DOI":"10.5326\/0420472","article-title":"Intranasal malignant melanoma in a dog","volume":"42","author":"Hicks","year":"2006","journal-title":"J. Am. Anim. Hosp. Assoc."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1080\/01652176.2017.1387828","article-title":"Intranasal melanoma treated with radiation therapy in three dogs","volume":"37","author":"Davies","year":"2017","journal-title":"Vet. Q."},{"key":"ref_49","first-page":"391","article-title":"Primary intranasal melanoma with brain invasion in a dog","volume":"58","author":"Lemetayer","year":"2017","journal-title":"Can. Vet. J."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1740-8261.2003.tb00468.x","article-title":"A retrospective analysis of 140 dogs with oral melanoma treated with external beam radiation","volume":"44","author":"Proulx","year":"2003","journal-title":"Vet. Radiol. Ultrasound"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/jsap.12624","article-title":"Outcome and prognostic factors following curative-intent surgery for oral tumours in dogs: 234 cases (2004 to 2014)","volume":"58","author":"Sarowitz","year":"2017","journal-title":"J. Small Anim. Pract."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.2460\/javma.245.11.1266","article-title":"Outcome following curative-intent surgery for oral melanoma in dogs: 70 cases (1998\u20132011)","volume":"245","author":"Tuohy","year":"2014","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1177\/0300985810390717","article-title":"Prognostic markers for canine melanocytic neoplasms: A comparative review of the literature and goals for future investigation","volume":"48","author":"Smedley","year":"2011","journal-title":"Vet. Pathol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0034-5288(02)00041-3","article-title":"Proliferation activity in oral and cutaneous canine melanocytic tumours: Correlation with histological parameters, location, and clinical behaviour","volume":"73","author":"Millanta","year":"2002","journal-title":"Res. Vet. Sci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1354\/vp.45-6-889","article-title":"Survival of dogs following surgical excision of histologically well-differentiated melanocytic neoplasms of the mucous membranes of the lips and oral cavity","volume":"45","author":"Esplin","year":"2008","journal-title":"Vet. Pathol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1532-950X.1992.tb01707.x","article-title":"Hemimaxillectomy for the treatment of oral tumors in 69 dogs","volume":"21","author":"Wallace","year":"1992","journal-title":"Vet. Surg."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1532-950X.1991.tb00346.x","article-title":"Results of Partial Mandibulectomy for the Treatment of Oral Tumors in 142 Dogs","volume":"20","author":"Kosovsky","year":"1991","journal-title":"Vet. Surg."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2460\/javma.245.4.401","article-title":"Efficacy of systemic adjuvant therapies administered to dogs after excision of oral malignant melanomas: 151 cases (2001\u20132012)","volume":"245","author":"Boston","year":"2014","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"72","DOI":"10.2460\/javma.248.1.72","article-title":"Palliative radiation therapy for solid tumors in dogs: 103 cases (2007\u20132011)","volume":"248","author":"Tollett","year":"2016","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1476-5810.2005.00082.x","article-title":"Oral malignant melanoma\u2014The effect of coarse fractionation radiotherapy alone or with adjuvant carboplatin therapy","volume":"3","author":"Murphy","year":"2005","journal-title":"Vet. Comp. Oncol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.2460\/javma.247.10.1146","article-title":"Outcomes of dogs undergoing radiotherapy for treatment of oral malignant melanoma: 111 cases (2006\u20132012)","volume":"247","author":"Kawabe","year":"2015","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1111\/vco.12122","article-title":"Efficacy and side effects of radiation therapy in comparison with radiation therapy and temozolomide in the treatment of measurable canine malignant melanoma","volume":"14","author":"Cancedda","year":"2016","journal-title":"Vet. Comp. Oncol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1939-1676.1994.tb03231.x","article-title":"0-7-21 radiation therapy for the treatment of canine oral melanoma","volume":"8","author":"Bateman","year":"1994","journal-title":"J. Vet. Intern. Med."},{"key":"ref_64","first-page":"96","article-title":"Treatment of dogs with oral melanoma by hypofractionated radiation therapy and platinum-based chemotherapy (1987\u20131997)","volume":"17","author":"Freeman","year":"2003","journal-title":"J. Vet. Intern. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.2460\/ajvr.2002.63.1129","article-title":"Activating mutations in the catalytic or juxtamembrane domain of c-kit in splenic mast cell tumors of cats","volume":"63","author":"Dank","year":"2002","journal-title":"Am. J. Vet. Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.2460\/javma.2001.218.1444","article-title":"Use of carboplatin for treatment of dogs with malignant melanoma: 27 cases (1989\u20132000)","volume":"218","author":"Rassnick","year":"2001","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_67","first-page":"8","article-title":"Vaccination with human tyrosinase DNA induces antibody responses in dogs with advanced melanoma","volume":"6","author":"Liao","year":"2006","journal-title":"Cancer Immun."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.vetimm.2015.11.003","article-title":"Cancer immunology and canine malignant melanoma: A comparative review","volume":"169","author":"Atherton","year":"2016","journal-title":"Vet. Immunol. Immunopathol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/vco.12057","article-title":"A retrospective analysis of the efficacy of Oncept vaccine for the adjunct treatment of canine oral malignant melanoma","volume":"11","author":"Ottnod","year":"2013","journal-title":"Vet. Comp. Oncol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.2460\/ajvr.72.12.1631","article-title":"Safety and efficacy of a xenogeneic DNA vaccine encoding for human tyrosinase as adjunctive treatment for oral malignant melanoma in dogs following surgical excision of the primary tumor","volume":"72","author":"Grosenbaugh","year":"2011","journal-title":"Am. J. Vet. Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.4102\/jsava.v86i1.1246","article-title":"Use of the melanoma vaccine in 38 dogs: The South African experience","volume":"86","author":"McLean","year":"2015","journal-title":"J. S. Afr. Vet. Assoc."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1292\/jvms.15-0510","article-title":"A retrospective review of outcome and survival following surgery and adjuvant xenogeneic DNA vaccination in 32 dogs with oral malignant melanoma","volume":"78","author":"Treggiari","year":"2016","journal-title":"J. Vet. Med. Sci."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/jsap.12613","article-title":"Use of Oncept melanoma vaccine in 69 canine oral malignant melanomas in the UK","volume":"58","author":"Verganti","year":"2017","journal-title":"J. Small Anim. Pract."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3109\/07357908609017520","article-title":"Canine oral melanoma: Comparison of surgery versus surgery plus Corynebacterium parvum","volume":"4","author":"MacEwen","year":"1986","journal-title":"Cancer Investig."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1177\/0300985810388947","article-title":"Prognostic evaluation of Ki67 threshold value in canine oral melanoma","volume":"48","author":"Bergin","year":"2011","journal-title":"Vet. Pathol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1476-5829.2010.00253.x","article-title":"Analysis of KIT expression and KIT exon 11 mutations in canine oral malignant melanomas","volume":"9","author":"Murakami","year":"2011","journal-title":"Vet. Comp. Oncol."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Mochizuki, H., Kennedy, K., Shapiro, S.G., and Breen, M. (2015). BRAF Mutations in Canine Cancers. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0129534"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10577-014-9444-6","article-title":"Comparative cytogenetic characterization of primary canine melanocytic lesions using array CGH and fluorescence in situ hybridization","volume":"23","author":"Poorman","year":"2015","journal-title":"Chromosome Res."},{"key":"ref_79","unstructured":"Hitte, C., Cadieu, E., Primot, A., Hedan, B., Abadie, J., Prouteau, A., Gillard, M., Botherel, N., Vergier, B., and De Brito, C. (2019). Integrated Genetic Analysis of Canine Mucosal Melanoma from Three Predisposed Breeds, in prep."},{"key":"ref_80","unstructured":"Cancer Genome Atlas Network (2015). Genomic Classification of Cutaneous Melanoma. Cell, 161, 1681\u20131696."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/path.5017","article-title":"Whole-exome sequencing of oral mucosal melanoma reveals mutational profile and therapeutic targets","volume":"244","author":"Lyu","year":"2018","journal-title":"J. Pathol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nature22071","article-title":"Whole-genome landscapes of major melanoma subtypes","volume":"545","author":"Hayward","year":"2017","journal-title":"Nature"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1126\/science.aau6509","article-title":"Human tumor genomics and zebrafish modeling identify SPRED1 loss as a driver of mucosal melanoma","volume":"362","author":"Ablain","year":"2018","journal-title":"Science"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1038\/bjc.2017.125","article-title":"Mutation status among patients with sinonasal mucosal melanoma and its impact on survival","volume":"116","author":"Amit","year":"2017","journal-title":"Br. J. Cancer"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/CMR.0000000000000345","article-title":"Whole-exome sequencing identifies recurrent SF3B1 R625 mutation and comutation of NF1 and KIT in mucosal melanoma","volume":"27","author":"Hintzsche","year":"2017","journal-title":"Melanoma Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"6511","DOI":"10.1038\/s41598-019-42839-x","article-title":"Genome-wide analysis of canine oral malignant melanoma metastasis-associated gene expression","volume":"9","author":"Selmic","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/vco.12044","article-title":"Comparative analysis of MAPK and PI3K\/AKT pathway activation and inhibition in human and canine melanoma","volume":"13","author":"Fowles","year":"2015","journal-title":"Vet. Comp. Oncol."},{"key":"ref_88","first-page":"210","article-title":"Update in genetic susceptibility in melanoma","volume":"3","author":"Potrony","year":"2015","journal-title":"Ann. Transl. Med."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1939-1676.1999.tb02173.x","article-title":"The molecular basis of canine melanoma: Pathogenesis and trends in diagnosis and therapy","volume":"13","author":"Modiano","year":"1999","journal-title":"J. Vet. Intern. Med."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1177\/030098587901600103","article-title":"Prognosis after surgical excision of canine melanomas","volume":"16","author":"Bostock","year":"1979","journal-title":"Vet. Pathol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1046\/j.1365-3164.2001.00236.x","article-title":"MIB-1 immunoreactivity correlates with biologic behaviour in canine cutaneous melanoma","volume":"12","author":"Laprie","year":"2001","journal-title":"Vet. Dermatol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0738-081X(94)90217-8","article-title":"Pigmented lesions of the skin","volume":"12","author":"Goldschmidt","year":"1994","journal-title":"Clin. Dermatol."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Silvestri, S., Porcellato, I., Mechelli, L., Menchetti, L., Rapastella, S., and Brachelente, C. (2018). Tumor Thickness and Modified Clark Level in Canine Cutaneous Melanocytic Tumors. Vet. Pathol.","DOI":"10.1177\/0300985818798094"},{"key":"ref_94","first-page":"981","article-title":"Post-surgical outcome and prognostic factors in canine malignant melanomas of the haired skin: 87 cases (2003\u20132015)","volume":"59","author":"Laver","year":"2018","journal-title":"Can. Vet. J."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/pcmr.12459","article-title":"The genomic landscape of cutaneous melanoma","volume":"29","author":"Zhang","year":"2016","journal-title":"Pigment Cell Melanoma Res."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/ng.3373","article-title":"Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma","volume":"47","author":"Law","year":"2015","journal-title":"Nat. Genet."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"4774","DOI":"10.1038\/s41467-018-06649-5","article-title":"Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways","volume":"9","author":"Duffy","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1354\/vp.44-3-355","article-title":"Diagnoses and clinical outcomes associated with surgically amputated canine digits submitted to multiple veterinary diagnostic laboratories","volume":"44","author":"Wobeser","year":"2007","journal-title":"Vet. Pathol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1939-1676.2005.tb02751.x","article-title":"Canine digital tumors: A veterinary cooperative oncology group retrospective study of 64 dogs","volume":"19","author":"Henry","year":"2005","journal-title":"J. Vet. Intern. Med."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1939-1676.2010.0627.x","article-title":"Xenogeneic murine tyrosinase DNA vaccine for malignant melanoma of the digit of dogs","volume":"25","author":"Manley","year":"2011","journal-title":"J. Vet. Intern. Med."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"726","DOI":"10.2460\/javma.1995.207.06.0726","article-title":"Evaluation of dogs with digit masses: 117 cases (1981\u20131991)","volume":"207","author":"Marino","year":"1995","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1056\/NEJMoa050092","article-title":"Distinct sets of genetic alterations in melanoma","volume":"353","author":"Curtin","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1177\/030098588602300411","article-title":"Morphology and behavior of primary ocular melanomas in 91 dogs","volume":"23","author":"Wilcock","year":"1986","journal-title":"Vet. Pathol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1177\/030098588302000401","article-title":"Primary Ocular Melanoma in Dogs","volume":"20","author":"Diters","year":"1983","journal-title":"Vet. Pathol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1046\/j.1463-5224.1999.00080.x","article-title":"A matched observational study of canine survival with primary intraocular melanocytic neoplasia","volume":"2","author":"Giuliano","year":"1999","journal-title":"Vet. Ophthalmol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/CMR.0000000000000297","article-title":"Melanocytoma-like melanoma may be the missing link between benign and malignant uveal melanocytic lesions in humans and dogs: A comparative study","volume":"26","author":"Zoroquiain","year":"2016","journal-title":"Melanoma Res."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/jsap.12141","article-title":"Investigation of prognostic indicators for human uveal melanoma as biomarkers of canine uveal melanoma metastasis","volume":"54","author":"Malho","year":"2013","journal-title":"J. Small Anim. Pract."},{"key":"ref_108","first-page":"415","article-title":"Canine uveal melanoma: Series and literature review","volume":"23","author":"Bussanich","year":"1987","journal-title":"J. Am. Anim. Hosp. Assoc."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1046\/j.1463-5224.2001.00130.x","article-title":"Suspected latent vertebral metastasis of uveal melanoma in a dog: A case report","volume":"4","author":"Rovesti","year":"2001","journal-title":"Vet. Ophthalmol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/ccr3.536","article-title":"Late prostatic metastasis of an uveal melanoma in a miniature Schnauzer dog","volume":"4","author":"Delgado","year":"2016","journal-title":"Clin. Case Rep."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1001\/archopht.123.12.1639","article-title":"Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group Report No. 26","volume":"123","author":"Reynolds","year":"2005","journal-title":"Arch. Ophthalmol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2353\/jmoldx.2010.090220","article-title":"An accurate, clinically feasible multi-gene expression assay for predicting metastasis in uveal melanoma","volume":"12","author":"Onken","year":"2010","journal-title":"J. Mol. Diagn."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1369\/0022155418766292","article-title":"Immunohistochemical Expression of FXR1 in Canine Normal Tissues and Melanomas","volume":"66","author":"Nordio","year":"2018","journal-title":"J. Histochem. Cytochem."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nature07586","article-title":"Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi","volume":"457","author":"Bezrookove","year":"2009","journal-title":"Nature"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/modpathol.2013.138","article-title":"Genetic and clinico-pathologic analysis of metastatic uveal melanoma","volume":"27","author":"Griewank","year":"2014","journal-title":"Mod. Pathol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1056\/NEJMoa1000584","article-title":"Mutations in GNA11 in uveal melanoma","volume":"363","author":"Griewank","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1093\/jnci\/djy171","article-title":"Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide","volume":"110","author":"Walpole","year":"2018","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Ewens, K.G., Lalonde, E., Richards-Yutz, J., Shields, C.L., and Ganguly, A. (2018). Comparison of Germline versus Somatic BAP1 Mutations for Risk of Metastasis in Uveal Melanoma. BMC Cancer, 18.","DOI":"10.1186\/s12885-018-5079-x"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41525-017-0008-5","article-title":"A GWAS in uveal melanoma identifies risk polymorphisms in the CLPTM1L locus","volume":"2","author":"Mobuchon","year":"2017","journal-title":"NPJ Genom. Med."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.det.2012.04.011","article-title":"Radiation Therapy for Cutaneous Melanoma","volume":"30","author":"Barker","year":"2012","journal-title":"Dermatol. Clin."},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Tyrrell, H., and Payne, M. (2018). Combatting mucosal melanoma: Recent advances and future perspectives. Melanoma Manag., 5.","DOI":"10.2217\/mmt-2018-0003"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s40425-018-0362-6","article-title":"An update on the Society for Immunotherapy of Cancer consensus statement on tumor immunotherapy for the treatment of cutaneous melanoma: Version 2.0","volume":"6","author":"Sullivan","year":"2018","journal-title":"J. Immunother. Cancer"},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Almela, R.M., and Ans\u00f3n, A. (2019). A Review of Immunotherapeutic Strategies in Canine Malignant Melanoma. Vet. Sci., 6.","DOI":"10.3390\/vetsci6010015"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nrclinonc.2017.43","article-title":"Targeted agents and immunotherapies: Optimizing outcomes in melanoma","volume":"14","author":"Luke","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1200\/JCO.2016.67.9258","article-title":"Efficacy and Safety of Nivolumab Alone or in Combination With Ipilimumab in Patients With Mucosal Melanoma: A Pooled Analysis","volume":"35","author":"Larkin","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Tagawa, M., Kurashima, C., Takagi, S., Maekawa, N., Konnai, S., Shimbo, G., Matsumoto, K., Inokuma, H., Kawamoto, K., and Miyahara, K. (2018). Evaluation of costimulatory molecules in dogs with B cell high grade lymphoma. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0201222"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1111\/vco.12294","article-title":"PD-1 expression by canine T cells and functional effects of PD-1 blockade","volume":"15","author":"Coy","year":"2017","journal-title":"Vet. Comp. Oncol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/vco.12197","article-title":"Immune regulation of canine tumour and macrophage PD-L1 expression","volume":"15","author":"Hartley","year":"2017","journal-title":"Vet. Comp. Oncol."},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Maekawa, N., Konnai, S., Ikebuchi, R., Okagawa, T., Adachi, M., Takagi, S., Kagawa, Y., Nakajima, C., Suzuki, Y., and Murata, S. (2014). Expression of PD-L1 on canine tumor cells and enhancement of IFN-\u03b3 production from tumor-infiltrating cells by PD-L1 blockade. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0098415"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"8951","DOI":"10.1038\/s41598-017-09444-2","article-title":"A canine chimeric monoclonal antibody targeting PD-L1 and its clinical efficacy in canine oral malignant melanoma or undifferentiated sarcoma","volume":"7","author":"Maekawa","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1200\/JCO.2012.47.7836","article-title":"Imatinib for Melanomas Harboring Mutationally Activated or Amplified KIT Arising on Mucosal, Acral, and Chronically Sun-Damaged Skin","volume":"31","author":"Hodi","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.tvjl.2013.08.003","article-title":"The proteasome inhibitor bortezomib inhibits the growth of canine malignant melanoma cells in vitro and in vivo","volume":"198","author":"Ito","year":"2013","journal-title":"Vet. J."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/104063870601800121","article-title":"Survey of equine cutaneous neoplasia in the Pacific Northwest","volume":"18","author":"Valentine","year":"2006","journal-title":"J. Vet. Diagn. Investig."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/ng.185","article-title":"A cis-acting regulatory mutation causes premature hair graying and susceptibility to melanoma in the horse","volume":"40","author":"Golovko","year":"2008","journal-title":"Nat. Genet."},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Sundstr\u00f6m, E., Imsland, F., Mikko, S., Wade, C., Sigurdsson, S., Pielberg, G.R., Golovko, A., Curik, I., Seltenhammer, M.H., and S\u00f6lkner, J. (2012). Copy number expansion of the STX17 duplication in melanoma tissue from Grey horses. BMC Genom., 13.","DOI":"10.1186\/1471-2164-13-365"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1111\/vco.12285","article-title":"Mutation analysis and gene expression profiling of ocular melanomas in cats","volume":"15","author":"Rushton","year":"2017","journal-title":"Vet. Comp. Oncol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1177\/1098612X15625355","article-title":"Non-ocular melanomas in cats: A retrospective study of 30 cases","volume":"19","author":"Chamel","year":"2017","journal-title":"J. Feline Med. Surg."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1593\/neo.08344","article-title":"Gene expression signature for spontaneous cancer regression in melanoma pigs","volume":"10","author":"Rambow","year":"2008","journal-title":"Neoplasia"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"27682","DOI":"10.18632\/oncotarget.25455","article-title":"New susceptibility loci for cutaneous melanoma risk and progression revealed using a porcine model","volume":"9","author":"Bourneuf","year":"2018","journal-title":"Oncotarget"},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Gordon, I., Paoloni, M., Mazcko, C., and Khanna, C. (2009). The Comparative Oncology Trials Consortium: Using spontaneously occurring cancers in dogs to inform the cancer drug development pathway. PLoS Med., 6.","DOI":"10.1371\/journal.pmed.1000161"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"324ps5","DOI":"10.1126\/scitranslmed.aaf0746","article-title":"Perspectives from man\u2019s best friend: National Academy of Medicine\u2019s Workshop on Comparative Oncology","volume":"8","author":"LeBlanc","year":"2016","journal-title":"Sci. Transl. Med."}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/10\/7\/501\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:02:39Z","timestamp":1760187759000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/10\/7\/501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,30]]},"references-count":141,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2019,7]]}},"alternative-id":["genes10070501"],"URL":"https:\/\/doi.org\/10.3390\/genes10070501","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,30]]}}}